Beijing Meilian Tyco Biotechnology

Manufacturer of pathology and diagnostic products

placeBeijing, Beijing, China calendar_todayFounded 2017 groups200 employees language sophonix.net

Innovation

5 patent families (1 granted) — focus: Operations & transport, Physics & computing; filing pace dormant. Cited 40 times.

YearFilings
20191
20204

Investor mix

8 investors on record; lead investors include Delian Capital, Anlong Fund, Cathay Financial Holdings, Mingshi Investment Management.

Investor typeCountShare
Venture capital338%
Private equity113%
Other / undisclosed450%
Coming soon